Anacélia Matos, Silvia M M Magalhães, Michael J Rauh - Immune dysregulation and recurring mutations in myelodysplastic syndromes pathogenesis.
Debojyoti De, Parimal Karmakar, Debalina Bhattacharya - Stem Cell Aging and Regenerative Medicine.
Drashti Desai, R. S. Gaud, Pravin Shende - Potential of Chimeric Antigen Receptor T-cells in cancer therapy.
Ekene Nweke, Deepak B. Thimiri Govindaraj - Drug sensitivity and drug repurposing platform for cancer precision medicine.
Fernando Faunes -Role and regulation of Lin28 in progenitor cells during central nervous system development.
Leila Taghiyar, Shahrbano Jahangir, Mojtaba Khozaei Ravari, Mohammad Amin Shamekhi,Mohamadreza Baghaban Eslaminejad -Cartilage Repair by Mesenchymal Stem Cell-Derived Exosomes: Preclinicaland Clinical Trial Update and Perspectives.
Mabel Catalán; Catalina Rodríguez; Ivonne Olmedo; Javiera Carrasco-Rojas; DiegoRojas, Alfredo Molina-Berríos; Mario Díaz-Dosque José A. Jara - Kaempferol induce cell death and sensitizes human head and neck squamous cell carcinoma cell lines to cisplatin.
Marco Folci, Giacomo Ramponi, Enrico Brunetta - A comprehensive approach to Urticaria: from clinical presentation to modern biological treatments through pathogenesis.
Mrinal K Das, Taral R Lunavat, Hrvoje Miletic, Jubayer A Hossain -The potentials and pitfalls of using adult stem cells in cancer treatment.
Peyvand Parhizkar Roudsari, Sepideh Alavi-Moghadam, Mostafa Rezaei-Tavirani, Parisa Goodarzi, Akram Tayanloo-Beik, Forough Azam Sayahpour; Bagher Larijani, Babak Arjmand – The Outcome of Stem Cell-Based Therapies on the Immune Responses in Rheumatoid Arthritis.
Much research has focused on the basic cellular and molecular biological aspects of stem cells. Much of this research has been fueled by their potential for use in regenerative medicine applications, which has in turn spurred growing numbers of translational and clinical studies. However, more work is needed if the potential is to be realized for improvement of the lives and well-being of patients with numerous diseases and conditions.
This book series 'Cell Biology and Translational Medicine (CBTMED)' as part of Springer Nature’s long-standing and very successful Advances in Experimental Medicine and Biology book series, has the goal to accelerate advances by timely information exchange. Emerging areas of regenerative medicine and translational aspects of stem cells are covered in each volume. Outstanding researchers are recruited to highlight developments and remaining challenges in both the basic research and clinical arenas. This current book is the twelfth volume of a continuing series.